Clinical Trials in Nashville

Showing 5801-5820 of 20,298 trials

Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome

NCT01968187

The purpose of this study is to evaluate the safety and effectiveness of intranasal FE 992097 in children and adults with Prader-Willi Syndrome.

Hyperphagia in Prader-Willi Syndrome

Ferring Pharmaceuticals38 participantsStarted Jan 2014

Gainesville, Florida, United States • Mineola, New York, United States • Nashville, Tennessee, United States

TERMINATEDPhase 2< 1 mile

Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC

NCT04952753

The purpose of this study is to evaluate the preliminary efficacy and safety of NIS793 and other novel investigational combinations with standard of care (SOC) anti-cancer therapy vs SOC anti-cancer therapy for the second line treatment of mCRC. This study aims to explore whether different mechanisms of action may reverse resistance and improve responsiveness to the currently considered SOC anti-cancer therapy in the second line metastatic colorectal cancer (mCRC) setting.

Metastatic Colorectal Cancer

Novartis Pharmaceuticals204 participantsStarted Nov 2021

Los Angeles, California, United States • Ann Arbor, Michigan, United States • St Louis, Missouri, United States +52 more locations

Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome

Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC

Find Trials by Condition in Nashville

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging

Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors

Zuranolone Pharmacokinetics (PK) and Safety Study Adolescent Participants With Major Depressive Disorder (MDD)

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Outcomes of a Skill-Based Program for Eating Disorders

A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)

PArtial REbreathing for Migraine With Aura 1

Urine CXCL10 Monitoring Trial in Kidney Transplant

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female Subjects

Efficacy of Emotionally Focused Therapy Among Spanish Speaking Couples